The comparative development of elevated resistance to macrolides in community-acquired pneumonia caused by Streptococcus pneumoniae

@inproceedings{Yayan2014TheCD,
  title={The comparative development of elevated resistance to macrolides in community-acquired pneumonia caused by Streptococcus pneumoniae},
  author={Josef Yayan},
  booktitle={Drug design, development and therapy},
  year={2014}
}
BACKGROUND Community-acquired pneumonia (CAP) is an acute inflammation of the lungs, which is often caused by Streptococcus pneumoniae. CAP is the leading cause of death by infectious disease in industrialized countries. Therefore, an immediate and effective antibiotic therapy is of great importance for the nonfatal outcome of the disease. The literature contains increasing data about the development of resistance to antibiotics that are used for the treatment of CAP caused by S. pneumoniae… CONTINUE READING